PL2097066T3 - Mikrostrukturalne preparaty białkowe z zaadsorbowanymi substancjami biologicznie czynnymi oraz ich zastosowanie w medycynie i kosmetyce - Google Patents

Mikrostrukturalne preparaty białkowe z zaadsorbowanymi substancjami biologicznie czynnymi oraz ich zastosowanie w medycynie i kosmetyce

Info

Publication number
PL2097066T3
PL2097066T3 PL07834906T PL07834906T PL2097066T3 PL 2097066 T3 PL2097066 T3 PL 2097066T3 PL 07834906 T PL07834906 T PL 07834906T PL 07834906 T PL07834906 T PL 07834906T PL 2097066 T3 PL2097066 T3 PL 2097066T3
Authority
PL
Poland
Prior art keywords
microstructural
cosmetics
medicine
application
biologically active
Prior art date
Application number
PL07834906T
Other languages
English (en)
Inventor
Andrzej Lipkowski
Anna Grabowska
Katarzyna Kurzepa
Aleksandra Szczucińska
Original Assignee
Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego filed Critical Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego
Publication of PL2097066T3 publication Critical patent/PL2097066T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/148Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL07834906T 2006-11-21 2007-11-20 Mikrostrukturalne preparaty białkowe z zaadsorbowanymi substancjami biologicznie czynnymi oraz ich zastosowanie w medycynie i kosmetyce PL2097066T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL381103A PL227142B1 (pl) 2006-11-21 2006-11-21 Mikrostrukturalny preparat białkowy zawierajacy zwiazki biologicznie czynne
EP07834906.5A EP2097066B1 (en) 2006-11-21 2007-11-20 Microstructural protein preparations containing adsorbed biologically active substances and their application in medicine and cosmetics

Publications (1)

Publication Number Publication Date
PL2097066T3 true PL2097066T3 (pl) 2017-04-28

Family

ID=39048813

Family Applications (2)

Application Number Title Priority Date Filing Date
PL381103A PL227142B1 (pl) 2006-11-21 2006-11-21 Mikrostrukturalny preparat białkowy zawierajacy zwiazki biologicznie czynne
PL07834906T PL2097066T3 (pl) 2006-11-21 2007-11-20 Mikrostrukturalne preparaty białkowe z zaadsorbowanymi substancjami biologicznie czynnymi oraz ich zastosowanie w medycynie i kosmetyce

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL381103A PL227142B1 (pl) 2006-11-21 2006-11-21 Mikrostrukturalny preparat białkowy zawierajacy zwiazki biologicznie czynne

Country Status (4)

Country Link
US (1) US8715701B2 (pl)
EP (1) EP2097066B1 (pl)
PL (2) PL227142B1 (pl)
WO (1) WO2008063092A2 (pl)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2854381A (en) * 1955-12-08 1958-09-30 Bristol Myers Co Resin laxative tablets containing hydrolyzed keratin
US5058686A (en) * 1986-10-27 1991-10-22 Mickey Redwine Sliding-weight operated hole boring tool
US5232875A (en) * 1992-10-15 1993-08-03 Micron Technology, Inc. Method and apparatus for improving planarity of chemical-mechanical planarization operations
JP3231013B2 (ja) * 1997-12-04 2001-11-19 一丸ファルコス株式会社 抗菌加工繊維類の製造法
US6544548B1 (en) * 1999-09-13 2003-04-08 Keraplast Technologies, Ltd. Keratin-based powders and hydrogel for pharmaceutical applications
JP3430257B2 (ja) * 2000-08-30 2003-07-28 独立行政法人農業生物資源研究所 有害物質の吸着素材及び有害物質の脱着方法
WO2003064449A2 (en) * 2002-01-28 2003-08-07 Keraplast Technologies, Ltd. Bioactive keratin peptides
US20050232875A1 (en) * 2002-07-25 2005-10-20 Umeda Jimusho Ltd. Water-soluble keratin derivative and use thereof
US7163321B2 (en) * 2002-07-25 2007-01-16 Steven Contarino Emergency vehicle grille
BR0316793A (pt) 2002-11-28 2005-11-01 Keratec Ltd Formulações de cuidado pessoal contendo queratina
JP2006078227A (ja) * 2004-09-07 2006-03-23 Shinshu Univ タンパク質コロイド水溶液およびそれを含む模擬血液
US8920827B2 (en) * 2005-10-21 2014-12-30 Wake Forest University Health Sciences Keratin bioceramic compositions
DE102005063062A1 (de) * 2005-12-29 2007-07-05 Henkel Kgaa Synergistische Proteinhydrolysat-Kombinationen zur Behandlung reifer Haut
DE102006032665A1 (de) 2006-07-13 2008-01-17 Beiersdorf Ag Haarstylingzubereitung mit besonderen Proteinhydrolysaten

Also Published As

Publication number Publication date
WO2008063092A2 (en) 2008-05-29
EP2097066B1 (en) 2016-08-10
EP2097066A2 (en) 2009-09-09
PL381103A1 (pl) 2008-05-26
US8715701B2 (en) 2014-05-06
WO2008063092A3 (en) 2009-05-14
PL227142B1 (pl) 2017-11-30
US20100047196A1 (en) 2010-02-25

Similar Documents

Publication Publication Date Title
PL2269631T3 (pl) Kompozycje farmaceutyczne zawierające neurotoksynę botulinową do zastosowania w medycynie i kosmetyce
IL222880A (en) Peptides and their use in the treatment and diagnosis of diseases and pharmaceutical preparations containing them
EP1758617A4 (en) STABLE LIQUID AND LYOPHILIZED PROTEIN FORMULATIONS
IL195491A (en) Pharmaceutical compositions of tmc278 and processes for their preparation
GB2437875B (en) Skin care composition comprising L-carnosine and N-acetylcysteine
PL2803663T3 (pl) Inhibitory ludzkiej białkowej fosfatazy tyrozynowej i ich zastosowanie farmaceutyczne
IL180434A0 (en) Human glucagon - like - peptide - 1 modulators and their use in the treatment of diabetes and related conditions
EP2192179A4 (en) CDH3 PEPTIDE AND MEDICINAL AGENT COMPRISING SAME
GB0523576D0 (en) Drug composition and its use in therapy
IL193268A0 (en) Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia
IL181126A0 (en) Preparation of gold-containing nano-liposome particles and their use in medical therapy
IL205290A (en) A variant of human neurorthin protein, or its active biological part, containing medicinal preparations, and its use in the preparation of therapeutic drugs
ZA200610786B (en) Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions
PL2097066T3 (pl) Mikrostrukturalne preparaty białkowe z zaadsorbowanymi substancjami biologicznie czynnymi oraz ich zastosowanie w medycynie i kosmetyce
PL361364A1 (pl) Peptyd i kompozycja farmaceutyczna oraz ich zastosowania medyczne
EP1901701A4 (en) BODY CARE AND MEDICAL PRODUCTS WITH JOINED SULFUR ORGANIC GROUPS
AU2003271016A1 (en) Use of n-acetyl-d-aminoglycosamine in preparation of drugs for the treatment of cacer and metastasis
ZA200900899B (en) Protein matrix vaccines and methods of making and administering such vaccines
ATE456573T1 (de) Nmb0928-protein und dessen verwendung in pharmazeutischen formulierungen
FR2915394B1 (fr) Composition pharmaceutique et/ou cosmetique contenant des peptides
FR2915396B1 (fr) Composition pharmaceutique et/ou cosmetique contenant des peptides
FR2907681B1 (fr) Composition pharmaceutique et/ou cosmetique contenant des polypeptides ou des peptides.
FR2915395B1 (fr) Composition pharmaceutique et/ou cosmetique contenant des peptides
GB0409770D0 (en) Pharmaceutical preparations and their uses
HK1121374A (en) Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease